Now showing items 1-1 of 1

    • A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties 

      Kastrati, I.; Litosh, V. A.; Zhao, S.; Alvarez, Manuel G.; Thatcher, G. R. J.; Frasor, J. (BioMed Central, 2015-11-04)
      Introduction: Activation of cyclooxygenase (COX)/prostaglandin and nuclear factor κB (NFκB) pathways can promote breast tumor initiation, growth, and progression to drug resistance and metastasis. Thus, anti-inflammatory ...